Chemopreventive role of olive oil in colon carcinogenesis by targeting noncoding RNAs and methylation machinery

International Journal of Cancer

Volumn 144, Issue 5, 2019, Pages 1180-1194

  Nanda, Neha ^a,b,c   Mahmood, Safrun ^b   Bhatia, Alka ^b   Mahmood, Akhtar ^c   Dhawan, Devinder Kumar ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^c PANJAB UNIVERSITY   (India)

Author keywords

chemoprevention; colon cancer; methylation; miRNA; olive oil

Indexed keywords

1,2 DIMETHYLHYDRAZINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA; OLIVE OIL; UNTRANSLATED RNA; TUMOR MARKER;

1,2-DIMETHYLHYDRAZINE-INDUCED COLON CARCINOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CHEMOPROPHYLAXIS; COLON CARCINOGENESIS; CONTROLLED STUDY; EPIGENETICS; GENE ACTIVITY; GENE EXPRESSION; GENE MUTATION; GENE SILENCING; GENE TARGETING; GENETIC ASSOCIATION; HIGH RESOLUTION MELTING ANALYSIS; IMMUNOHISTOCHEMISTRY; INCIDENCE; MALE; MICROSCOPY; MOLECULARLY TARGETED THERAPY; MRNA EXPRESSION ASSAY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; RNA METHYLATION; THERAPY EFFECT; TUMOR VOLUME; ANIMAL; CARCINOGENESIS; COLON TUMOR; DNA METHYLATION; DRUG EFFECT; GENETIC EPIGENESIS; GENETICS; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; APOPTOSIS; BIOMARKERS, TUMOR; CARCINOGENESIS; COLONIC NEOPLASMS; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION; MALE; MICRORNAS; NF-KAPPA B; OLIVE OIL; PROMOTER REGIONS, GENETIC; RATS; RATS, SPRAGUE-DAWLEY; RNA, UNTRANSLATED;

EID: 85054401241     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.31837     Document Type: Article

References (74)

1. American Cancer Society. Colorectal cancer facts & figures 2014–2016, Atlanta: American Cancer Society, 2014
2. Link A, Balaguer F, Shen Y, et al. Curcumin modulates DNA methylation in colorectal cancer cells. PLoS One 2013;8:57709
3. Wang S, Liu Z, Wang L, et al. NF-kappa B signaling pathway, inflammation and colorectal cancer. Cell Mol Immunol 2009;6:327–34
4. Deveraux QL, Reed JC. IAP family proteins-suppressors of apoptosis. Gene Dev 1999;13:239–52
5. Karin M, Cao Y, Greten F, et al. NF-κB in cancer: from innocent bystander to major culprit. Nature Rev Cancer 2002;2:301–10
6. Ghavami S, Hashemi M, Ande SR, et al. Apoptosis and cancer: mutations within caspase genes. J Med Genet 2009;46:497–510
7. Baylin SB, Esteller M, Rountree MR, et al. Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum Mol Genet 2001;10:687–92
8. Kass SU, Landsberger N, Wolffe AP. DNA methylation directs a time-dependent repression of transcription initiation. Curr Biol 1997;7:157–65
9. Clark SJ, Melki J. DNA methylation and gene silencing in cancer: which is the guilty party? Oncogene 2002;21:5380–7
10. Frigola J, Solé X, Paz MF, et al. Differential DNA hypermethylation and hypomethylation signatures in colorectal cancer. Hum Mol Genet 2005;14:319–26
11. Lopez-Serra P, Esteller M. DNA methylation-associated silencing of tumor suppressor microRNAs in cancer. Oncogene 2012;31:1609–22
12. Suzuki H, Maruyama R, Yamamoto E, et al. DNA methylation and microRNA dysregulation in cancer. Mol Oncol 2012;6:567–78
13. Gao W, Yu Y, Cao H, et al. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis. Biomed Pharmacother 2010;64:399–08
14. Bockmeyer CL, Christgen M, Müller M, et al. MicroRNA profiles of healthy basal and luminal mammary epithelial cells are distinct and reflected in different breast cancer subtypes. Breast Cancer Res Treat 2011;130:735–45
15. Li Y, Tollefsbol TO. Impact on DNA methylation in cancer prevention and therapy by bioactive dietary components. Curr Med Chem 2010;17:2141–51
16. Moga MA, Dimienescu OG, Arvatescu CA, et al. The role of natural polyphenols in the prevention and treatment of cervical cancer-an overview. Molecules 2016;17:21
17. Reddy BS. Introduction: novel approaches to the prevention of colon cancer by nutritional manipulation and chemoprevention. Cancer Epidemiol Biomarkers Prev 2000;9:3
18. Tripoli E, Giammanco M, Tabacchi G, et al. The phenolic compounds of olive oil: structure, biological activity and beneficial effects on human health. Nutr Res Rev 2005;18:98–112
19. Waterman E, Lockwood B. Active components and clinical applications of olive oil. Altern Med Rev 2007;12:331–42
20. Rahman MA, Amin AR, Shin DM. Chemopreventive potential of natural compounds in head and neck cancer. Nutr Cancer 2010;62:973–87
21. Casaburi I, Puoci F, Chimento A, et al. Potential of olive oil phenols as chemopreventive and therapeutic agents against cancer: a review of in vitro studies. Mol Nutr Food Res 2013;57:71–3
22. França Fda S, Bodack C, Costa A, et al. The effect of dietary oils on the development of aberrant crypt foci, bifido bacteria and fecal pH. In Vivo 2014;28:197–203
23. 1 tumor suppressor gene in human colon cancer cells and in rat colon via epigenetic mechanisms. J Nutr Biochem 2015;26:250–8
24. Rodríguez-Miguel C, Moral R, Escrich R, et al. The role of dietary extra virgin olive oil and corn oil on the alteration of epigenetic patterns in the rat DMBA-induced breast cancer model. PLoS One 2015;10:e0138980
25. Soler AP, Miller RD, Laughlin KV, et al. Increased tight junctional permeability is associated with the development of colon cancer. Carcinogenesis 1999;20:1425–31
26. Chadha VD, Vaiphei K, Dhawan DK. Zinc mediated normalization of histoarchitecture and antioxidant status offers protection against initiation of experimental carcinogenesis. Mol Cell Biochem 2007;304:101–8
27. Banerjee S, Bueso-Ramos C, Aggarwal BB. Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Res 2002;62:4945–54
28. Imaoka T, Nishimura M, Teramoto A, et al. Cooperative induction of rat mammary cancer by radiation and 1-methyl-1-nitrosourea via the oncogenic pathways involving c-Myc activation and H-ras mutation. Int J Cancer 2005;115:187–93
29. Pettan-Brewer C, Morton J, Cullen S, et al. Tumor growth is suppressed in mice expressing a truncated XRCC1 protein. Am J Cancer Res 2012;2:168–77
30. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (−DeltaDelta C (T)) method. Methods 2001;25:402–8
31. Migheli F, Stoccoro A, Coppede F, et al. Comparison study of MS-HRM and pyrosequencing techniques for quantification of APC and CDKN2A gene methylation. PLoS One 2013;8:e52501
32. Wojdacz TK, Dobrovic A. Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation. Nucleic Acids Res 2007;35:e41
33. Nanda N, Dhawan DK, Bhatia A, et al. Doxycycline promotes carcinogenesis & metastasis via chronic inflammatory pathway: an in vivo approach. PLoS One 2016;11:e0151539
34. Li W, Li CB. Effect of oral Lactococcuslactis containing endostatin on 1,2- dimethylhydrazine-induced colon tumor in rats. World J Gastroenterol 2005;11:7242–7
35. Yu LN, Zhang QL, Li X, et al. Tiam1 transgenic mice display increased tumor invasive and metastatic potential of colorectal cancer after 1,2-dimethylhydrazine treatment. PLoS One 2013;8:73077
36. Sánchez-Fidalgo S, Villegas I, Cárdeno A, et al. Extra-virgin olive oil enriched diet modulates DSS-colitis-associated colon carcinogenesis in mice. Clin Nutr 2010;29:663–73
37. Horst D, Budczies J, Brabletz T, et al. Invasion associated up-regulation of nuclear factor kappa B target genes in colorectal cancer. Cancer 2009;115:4946–58
38. Vaiopoulos AG, Athanasoula KC, Papavassiliou AG. NF-κB in colorectal cancer. J Mol Med (Berl) 2013;91:1029–37
39. Gambhir S, Vyas D, Hollis M, et al. Nuclear factor kappa B role in inflammation associated gastrointestinal malignancies. World J Gastroenterol 2015;21:3174–83
40. Kunnumakkara AB, Diagaradjane P, Guha S, et al. Curcumin sensitizes human colorectal cancer xenografts in nude mice to gamma-radiation by targeting nuclear factor-kappa B-regulated gene products. Clin Cancer Res 2008;14:2128–36
41. Kunnumakkara AB, Guha S, Krishnan S, et al. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. Cancer Res 2007;67:3853–61
42. Boss A, Bishop KS, Marlow G, et al. Evidence to support the anti-cancer effect of olive leaf extract and future directions. Nutrients 2016;8:513
43. Jones PA, Laird PW. Cancer epigenetics comes of age. Nat Genet 1999;21:163–7
44. Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 2000;16:168–74
45. Taberlay PC, Jones PA. DNA methylation and cancer. Prog Drug Res 2011;67:1–23
46. Robertson KD. DNA methylation, methyltransferases, and cancer. Oncogene 2001;20:3139–55
47. Nagaraju GP, Zhu S, Wen J, et al. Novel synthetic curcumin analogues EF31 and UBS109 are potent DNA hypomethylating agents in pancreatic cancer. Cancer Lett 2013;341:195–203
48. Liu S, Liu Z, Xie Z, et al. Bortezomib induces DNA hypomethylation and silenced gene transcription by interfering with Sp1/NFkappa B-dependent DNA methyltransferase activity in acute myeloid leukemia. Blood 2008;111:2364–73
49. Kim JY, Hwang JH, Zhou W, et al. The expression of VEGF receptor genes is concurrently influenced by epigenetic gene silencing of the genes and VEGF activation. Epigenetics 2009;4:313–21
50. Farias LC, Gomes CC, Rodrigues MC, et al. Epigenetic regulation of matrix metalloproteinase expression in ameloblastoma. BMC Clin Pathol 2012;12:11
51. Shukeir N, Pakneshan P, Chen G, et al. Alteration of the methylation status of tumor-promoting genes decreases prostate cancer cell invasiveness and tumorigenesis in vitro and in vivo. Cancer Res 2006;66:9202–10
52. Odabasoglu F, Yildirim OS, Aygun H, et al. Diffractaic acid, a novel proapoptotic agent, induces with olive oil both apoptosis and antioxidative systems in Ti-implanted rabbits. Eur J Pharmacol 2012;674:171–8
53. Leong KH, Looi CY, Loong XM, et al. Cycloart-24-ene-26-ol-3-one, a new Cycloartane isolated from leaves of Aglaia exima triggers tumour necrosis factor-receptor 1-mediated Caspase-dependent apoptosis in colon cancer cell line. PLoS One 2016;11:e0152652
54. Fulda S, Kufer MU, Meyer E, et al. Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer. Oncogene 2001;20:5865–77
55. Hervouet E, Cheray M, Vallette FM, et al. DNA methylation and apoptosis resistance in cancer cells. Cell 2013;2:545–73
56. Trichopoulou A, Lagiou P, Kuper H, et al. Cancer and Mediterranean dietary traditions. Cancer Epidemiol Biomarkers Prev 2000;9:869–73
57. Rosato V, Guercio V, Bosetti C, et al. Mediterranean diet and colorectal cancer risk: a pooled analysis of three Italian case-control studies. Br J Cancer 2016;115:862–5
58. Jacobs S, Harmon BE, Ollberding NJ, et al. Among 4 diet quality indexes, only the alternate Mediterranean diet score is associated with better colorectal cancer survival and only in African American women in the multiethnic cohort. J Nutr 2016;146:1746–55
59. Jones P, Cade JE, Evans CEL, et al. The Mediterranean diet and risk of colorectal cancer in the UKWomen's cohort study. Int J Epidemiol 2017;46:1786–96
60. Toledo E, Salas-Salvadó J, Donat-Vargas C, et al. Mediterranean diet and invasive breast cancer risk among women at high cardiovascular risk in the PREDIMED trial: a randomized clinical trial. JAMA Intern Med 2015;175:1752–60
61. Kasinski AL, Slack FJ. Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer 2011;11:849–64
62. Chen X, Shi K, Wang Y, et al. Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation. Oncotarget 2015;6:37544–56
63. Meng WJ, Yang L, Ma Q, et al. MicroRNA expression profile reveals miR-17-92 and miR-143-145 cluster in synchronous colorectal cancer. Medicine (Baltimore) 2015;94:e1297
64. Borralho PM, Kren BT, Castro RE, et al. MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells. FEBS J 2009;276:6689–700
65. Zhang J, Wang L, Li B, et al. miR-145 downregulates the expression of cyclin-dependent kinase 6 in human cervical carcinoma cells. Exp Ther Med 2014;8:591–4
66. Zhang X, Liu S, Hu T, et al. Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression. Hepatology 2009;50:490–9
67. Feng Z, Zhang C, Wu R, et al. Tumor suppressor p53 meets microRNAs. J Mol Cell Biol 2011;3:44–50
68. Gomes SE, Simões AE, Pereira DM, et al. miR-143 or miR-145 over-expression increases cetuximab-mediated antibody-dependent cellular cytotoxicity in human colon cancer cells. Oncotarget 2016;7:9368–87
69. Su J, Liang H, Yao W, et al. MiR-143 and MiR-145 regulate IGF1R to suppress cell proliferation in colorectal cancer. PLoS One 2014;9:e114420
70. Grady WM, Parkin RK, Mitchell PS, et al. Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer. Oncogene 2008;27:3880–8
71. Vrba L, Munoz-Rodriguez JL, Stampfer MR, et al. miRNA gene promoters are frequent targets of aberrant DNA methylation in human breast cancer. PLoS One 2013;8:54398
72. Dou L, Zheng D, Li J, et al. Methylation-mediated repression of microRNA-143 enhances MLL-AF4 oncogene expression. Oncogene 2012;31:507–17
73. Donzelli S, Mori F, Bellissimo T, et al. Epigenetic silencing of miR-145-5p contributes to brain metastasis. Oncotarget 2015;6:35183–201
74. Wang LQ, Liang R, Chim CS. Methylation of tumor suppressor microRNAs: lessons from lymphoid malignancies. Expert Rev Mol Diagn 2012;12:755–65